The molecular, cellular, tissue, organ and physiological mechanisms by which Tafazzin mutations propagate dysfunction across multiscale networks are poorly understood, and a deeper understanding of the components of these networks will likely provide fundamental advances in knowledge of mitochondrially associated disease mechanisms and the development of targeted therapies for mitochondrial disorders such as BTHS. The gene discussed is TAFAZZIN; the disease is Barth syndrome.